A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/1998
11/26/1998	CA2288741A1 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
11/26/1998	CA2288327A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/26/1998	CA2287977A1 Novel triptolide derivatives useful in the treatment of autoimmune diseases
11/25/1998	EP0879889A2 A novel member of the IL-1 family, IL-1 delta
11/25/1998	EP0879883A1 ATG-1120 (AIF-1-DELTA), a splice variant of AIF-1/RC-9
11/25/1998	EP0879882A1 ATG-1100 (AIF-1-Gamma), a splice variant of AIF-1/RC-9
11/25/1998	EP0879880A1 ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9
11/25/1998	EP0879879A2 Polypeptide deformylase 1 (Def1)
11/25/1998	EP0879814A1 Triaromatic compounds, compositions containing them and uses thereof
11/25/1998	EP0879605A2 Glycosyl prodrug conjugate with enhanced tolerance
11/25/1998	EP0879604A1 Konjugate comprising a Folic acid antagonist and a carrier
11/25/1998	EP0879294A1 Transduced human hematopoietic stem cells
11/25/1998	EP0879289A1 Human dnase resistant to actin inhibition
11/25/1998	EP0879285A1 Fas ligand fusion protein
11/25/1998	EP0879245A1 Synthetic il-10 analogues
11/25/1998	EP0879223A1 Aromatic polycyclic retinoid-type derivatives, method for preparing same, and use thereof for making pharmaceutical and cosmetic compositions
11/25/1998	EP0879060A1 Vaccines against varicella zoster virus gene 63 product
11/25/1998	EP0663916B1 O-alkylated rapamycin derivative and its use, particularly as immunosuppressant
11/25/1998	EP0661998B1 Therapeutic agent from mycobacterium vaccae and its use against hiv infection with aids
11/25/1998	EP0654994B1 Use of cineol or menthol for the treament of asthma
11/25/1998	EP0624159B1 Pyridyl substituted imidazoles
11/25/1998	EP0607252B1 Compositions for the treatment of hiv infection
11/25/1998	CN1200147A Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/25/1998	CN1200120A Piperazino derivatives as neurokinin antagonists
11/25/1998	CN1200115A Chiral methyl phenyl oxazolidinones
11/25/1998	CN1199643A Globular cellulose DNA immunoadsorbent
11/25/1998	CN1199613A Preparation having increased in vivo tolerability
11/25/1998	CN1040874C Triazolopyridazine compounds and its preparation, composition with said compound as its active ingredient
11/24/1998	US5840939 Derivatives of succinamide and their use as metalloproteinase inhibitors
11/24/1998	US5840921 Method for the preparation of aldol product 7B
11/24/1998	US5840869 DNA encoding interleukin-4 receptors
11/24/1998	US5840707 A protein or peptide formulation comprising a polynucleotide component, a negatively charge lipid component and a divalent cation component
11/24/1998	US5840695 Ectoparasite saliva proteins and apparatus to collect such proteins
11/24/1998	US5840682 Peptide antagonists of neurotensin
11/24/1998	US5840545 Immunoglubulins
11/24/1998	US5840544 DNA encoding rantes homolog from prostate
11/24/1998	US5840530 DNA encoding receptors for the beta-2 chain of human IL-12
11/24/1998	US5840526 Two heavy polypeptide chains with variable and constant regions including complete antigen binding sites; constant region lacks ch1 domain; increased ease of preparation by genetic engineering; medical diagnosis
11/24/1998	US5840337 Gelling liquid polyethylene glycol at room temperature with calcium acetate
11/24/1998	US5840316 Desensitization
11/24/1998	US5840304 Amino acid sequences and codes for t-cells
11/24/1998	US5840299 Binding and treatment of multiple sclerosis
11/24/1998	CA2088579C Agents that bind to vcam-1 and uses thereof
11/22/1998	CA2231017A1 A member of the frzb family, frazzled
11/22/1998	CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9
11/21/1998	CA2232811A1 Novel def1
11/20/1998	WO1998052549A2 Use of fumaric acid derivatives
11/19/1998	WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998	WO1998051349A1 Conjugate comprising a folic acid antagonist and a carrier
11/19/1998	WO1998051346A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
11/19/1998	WO1998051344A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998	WO1998051335A1 Methods of modulating immune coagulation
11/19/1998	WO1998051328A1 Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
11/19/1998	WO1998040483A3 28 human secreted proteins
11/19/1998	WO1998034640A3 Synthetic hiv gag genes
11/19/1998	WO1998031802A3 Secreted proteins and polynucleotides encoding them
11/19/1998	WO1998026061A3 Expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease
11/19/1998	CA2290067A1 Human tumor necrosis factor receptor-like 2 (tr2) antibodies
11/19/1998	CA2290021A1 Suppression of tumor necrosis factor alpha and vascular endothelial growth factor in therapy
11/19/1998	CA2289448A1 Conjugate comprising a folic acid antagonist and a carrier
11/19/1998	CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998	CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998	EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998	EP0878467A1 Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
11/18/1998	EP0877760A1 Mhc complexes and uses thereof
11/18/1998	EP0877733A1 Process for production of piperidine derivatives
11/18/1998	EP0877625A1 Immunomodulatory methods using oligosaccharides
11/18/1998	EP0877619A1 Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract
11/18/1998	EP0877605A2 Solid instant-release forms of administration and process for producing the same
11/18/1998	EP0877555A1 Method of inhibiting immune system destruction of transplanted viable cells
11/18/1998	EP0877554A1 Triterpene derivatives with immunosuppressant activity
11/18/1998	EP0724581B1 Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof
11/18/1998	EP0706514B1 Compounds and methods for inhibition of hiv and related viruses
11/18/1998	CN1199426A Antigenic preparations
11/18/1998	CN1199396A Novel azepanes and their ring homologues for therapy and prophylaxis of protein kinase mediated diseases
11/18/1998	CN1199045A Substituted 6- and 7-aminotetrahydroisoquinolinecarboxylic acids
11/17/1998	US5837812 Human islet, human brain and mouse brain glutamic acid decarboxylase GAD polypeptides
11/17/1998	US5837713 Treatment of eosinophil-associated pathologies by administration of topical anesthetics and glucocorticoids
11/17/1998	US5837690 Derivatives of triterpenoid acids and uses thereof.
11/17/1998	US5837499 Genetic engineering with polypeptides and dna molecules
11/17/1998	US5837490 Therapeutic, diagnostic, research uses
11/17/1998	US5837477 Hybrid; immunomodulatory properties
11/17/1998	US5837451 Identifying composition which affect kinase activity
11/17/1998	US5837264 Potentiation of immunogenic response
11/17/1998	US5837263 Useful for inducing an immune response to pathogenic leptospira as well as providing a diagnostic target for leptospirosis
11/17/1998	US5837248 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide
11/17/1998	US5837244 Treating a cell proliferative disorder
11/17/1998	US5837243 Therapeutic compounds comprised of anti-Fc receptor antibodies
11/15/1998	CA2237450A1 Preparation having increased in vivo tolerability
11/13/1998	CA2237382A1 Substituted 6- and 7-amino-tetrahydroisoquinolinecarboxylic acids
11/13/1998	CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998	WO1998050434A1 Methods for eosinophil depletion and compositions therefor
11/12/1998	WO1998050424A2 Human serine protease precursor
11/12/1998	WO1998050413A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens
11/12/1998	WO1998050399A1 Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
11/12/1998	WO1998050372A1 Substituted heterocycles and their use in medicaments
11/12/1998	WO1998050368A1 Benzimidazole derivative
11/12/1998	WO1998050066A1 Potentiation of the immune response through delivery of compounds binding a cytoplasmic dipeptidase
11/12/1998	WO1998050046A1 Use of cd26 inhibitor for the manufacture of a medicament for the treatment of hiv
11/12/1998	WO1998050035A1 Pharmaceutical compositions of tizoxanide and nitazoxanide

1 ... 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 ... 1172